Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Health News
FDA Approves TOBI Podhaler
The US Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
REFINE
conditions
(-)
Remove Infectious Disease filter
Infectious Disease
(-)
Remove Pulmonary filter
Pulmonary
(-)
Remove Pulmonary Disease filter
Pulmonary Disease
(-)
Remove Cystic Fibrosis filter
Cystic Fibrosis